Molecular Cancer Therapeutics CTRC-AACR San Antonio Breast Cancer Symposium
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Receive this page by email each issue: [Sign up for eTOCs]

Cover Image
Other Issues:
Contents: December 1 2003, Volume 2, Issue 12   [Index by Author]  [Cover Caption]
       Articles
       Acknowledgment to Reviewers
       Author Index
       Subject Index
Find articles in this issue containing these words:
[Search ALL Issues]


To see an article, click its [Full Text] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

Articles:

Adam Kashishian, Heather Douangpanya, Darcey Clark, Stephen T. Schlachter, C. Todd Eary, Justin G. Schiro, Hongmei Huang, Larry E. Burgess, Edward A. Kesicki, and James Halbrook
DNA-dependent protein kinase inhibitors as drug candidates for the treatment of cancer
Mol Cancer Ther 2003 2: 1257-1264. [Abstract] [Full Text] [PDF]  

Curtis D. Hose, Melinda Hollingshead, Edward A. Sausville, and Anne Monks
Induction of CYP1A1 in tumor cells by the antitumor agent 2-[4-amino-3-methylphenyl]-5-fluoro-benzothiazole: A potential surrogate marker for patient sensitivity
Mol Cancer Ther 2003 2: 1265-1272. [Abstract] [Full Text] [PDF]  

Roberto R. Rosato, Jorge A. Almenara, Yun Dai, and Steven Grant
Simultaneous activation of the intrinsic and extrinsic pathways by histone deacetylase (HDAC) inhibitors and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) synergistically induces mitochondrial damage and apoptosis in human leukemia cells
Mol Cancer Ther 2003 2: 1273-1284. [Abstract] [Full Text] [PDF]  

Arindam Dhar, June M. Brindley, Cristi Stark, Michael L. Citro, Larry K. Keefer, and Nancy H. Colburn
Nitric oxide does not mediate but inhibits transformation and tumor phenotype
Mol Cancer Ther 2003 2: 1285-1293. [Abstract] [Full Text] [PDF]  

Talia Miron, Marina Mironchik, David Mirelman, Meir Wilchek, and Aharon Rabinkov
Inhibition of tumor growth by a novel approach: In situ allicin generation using targeted alliinase delivery
Mol Cancer Ther 2003 2: 1295-1301. [Abstract] [Full Text] [PDF]  

Stéphane Honore, Kathy Kamath, Diane Braguer, Leslie Wilson, Claudette Briand, and Mary Ann Jordan
Suppression of microtubule dynamics by discodermolide by a novel mechanism is associated with mitotic arrest and inhibition of tumor cell proliferation
Mol Cancer Ther 2003 2: 1303-1311. [Abstract] [Full Text] [PDF]  

Zhichao Zhou, Rong-Rong Zhou, Hui Guan, Corazon D. Bucana, and Eugenie S. Kleinerman
E1A gene therapy inhibits angiogenesis in a Ewing's sarcoma animal model
Mol Cancer Ther 2003 2: 1313-1319. [Abstract] [Full Text] [PDF]  

Emiko L. Kreklau, Karen E. Pollok, Barbara J. Bailey, Naili Liu, Jennifer R. Hartwell, David A. Williams, and Leonard C. Erickson
Hematopoietic expression of O6-methylguanine DNA methyltransferase-P140K allows intensive treatment of human glioma xenografts with combination O6-benzylguanine and 1,3-bis-(2-chloroethyl)-1-nitrosourea
Mol Cancer Ther 2003 2: 1321-1329. [Abstract] [Full Text] [PDF]  

Joachim Gullbo, Charlotta Wallinder, Marcus Tullberg, Henrik Lövborg, Hans Ehrsson, Rolf Lewensohn, Peter Nygren, Kristina Luthman, and Rolf Larsson
Antitumor activity of the novel melphalan containing tripeptide J3 (L-prolyl-L-melphalanyl-p-L-fluorophenylalanine ethyl ester): Comparison with its m-L-sarcolysin analogue P2
Mol Cancer Ther 2003 2: 1331-1339. [Abstract] [Full Text] [PDF]  

Yuying Liu, Lawrence H. Cheung, Walter N. Hittelman, and Michael G. Rosenblum
Targeted delivery of human pro-apoptotic enzymes to tumor cells: In vitro studies describing a novel class of recombinant highly cytotoxic agents
Mol Cancer Ther 2003 2: 1341-1350. [Abstract] [Full Text] [PDF]  

Shuichi Taniguchi, Yasushi Mochida, Takeshi Uchiumi, Tomoko Tahira, Kenshi Hayashi, Koichi Takagi, Mitsuo Shimada, Yoshihiko Maehara, Hiroyuki Kuwano, Suminori Kono, Hitoo Nakano, Michihiko Kuwano, and Morimasa Wada
Genetic polymorphism at the 5' regulatory region of multidrug resistance 1 (MDR1) and its association with interindividual variation of expression level in the colon
Mol Cancer Ther 2003 2: 1351-1359. [Abstract] [Full Text] [PDF]  

Ramzi M. Mohammad, Ayad Al-Katib, Amro Aboukameel, Daniel R. Doerge, Fazlul Sarkar, and Omer Kucuk
Genistein sensitizes diffuse large cell lymphoma to CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone) chemotherapy
Mol Cancer Ther 2003 2: 1361-1368. [Abstract] [Full Text] [PDF]  

Yoon-Pin Lim, Lang-Shi Diong, Robert Qi, Brian J. Druker, and Richard J. Epstein
Phosphoproteomic fingerprinting of epidermal growth factor signaling and anticancer drug action in human tumor cells
Mol Cancer Ther 2003 2: 1369-1377. [Abstract] [Full Text] [PDF]  

Acknowledgment to Reviewers:

Acknowledgment to Reviewers
Mol Cancer Ther 2003 2: 1379-1380. [Full Text] [PDF]  

Author Index:

Author Index
Mol Cancer Ther 2003 2: 1381-1384. [Full Text] [PDF]  

Subject Index:

Subject Index Volume 2
Mol Cancer Ther 2003 2: 1385-1401. [Full Text] [PDF]  

To see an article, click its [Full Text] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 2004 by the American Association for Cancer Research.